Accelerating First-In-Class and Best-In-Class Programs Using a Large-Scale Digital Chemistry Strategy


Aleksey Gerasyuto
Vice President, Drug Discovery, Schrödinger


Drug discovery organizations across the globe are seeking to accelerate the rate at which they bring safe, effective therapeutics to patients. Yet the bar for clinical compounds remains high as competitive landscapes become crowded and easily druggable targets have been targeted. The most innovative companies are modernizing their R&D organizations with digital solutions that leverage the combined power of large-scale computational workflows and their own team’s scientific expertise to identify higher-quality molecules more rapidly. In this webinar, you’ll learn how a large-scale collaborative digital chemistry strategy is accelerating first-in-class and best-in-class programs across a range of target classes.